Correlation Between Beleave and Sonoma Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Beleave and Sonoma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beleave and Sonoma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beleave and Sonoma Pharmaceuticals, you can compare the effects of market volatilities on Beleave and Sonoma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beleave with a short position of Sonoma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beleave and Sonoma Pharmaceuticals.

Diversification Opportunities for Beleave and Sonoma Pharmaceuticals

0.0

Correlation Coefficient

Beleave  Sonoma Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Beleave and Sonoma is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Beleave and Sonoma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonoma Pharmaceuticals and Beleave is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beleave are associated (or correlated) with Sonoma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonoma Pharmaceuticals has no effect on the direction of Beleave i.e., Beleave and Sonoma Pharmaceuticals go up and down completely randomly.

Pair Corralation between Beleave and Sonoma Pharmaceuticals

If you would invest (100.00) in Beleave on September 20, 2024 and sell it today you would earn a total of  100.00  from holding Beleave or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Beleave  vs.  Sonoma Pharmaceuticals

Beleave

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Beleave has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Beleave is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Sonoma Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sonoma Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Beleave and Sonoma Pharmaceuticals

The main advantage of trading using opposite Beleave and Sonoma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beleave position performs unexpectedly, Sonoma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonoma Pharmaceuticals will offset losses from the drop in Sonoma Pharmaceuticals' long position.

The idea behind Beleave and Sonoma Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.